相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Oxidative Damage in Clinical Ischemia/Reperfusion Injury: A Reappraisal
Dorottya K. de Vries et al.
ANTIOXIDANTS & REDOX SIGNALING (2013)
THE CONCISE GUIDE TO PHARMACOLOGY 2013/14: ENZYMES
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
THE CONCISE GUIDE TO PHARMACOLOGY 2013/14: G PROTEIN-COUPLED RECEPTORS
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Signaling pathways involved in isoprostane-mediated fibrogenic effects in rat hepatic stellate cells
Alessandra Acquaviva et al.
FREE RADICAL BIOLOGY AND MEDICINE (2013)
Isoprostanes in clinically isolated syndrome and early multiple sclerosis as biomarkers of tissue damage and predictors of clinical course
Emilia Sbardella et al.
MULTIPLE SCLEROSIS JOURNAL (2013)
Isoprostanes and neuroprostanes: Total synthesis, biological activity and biomarkers of oxidative stress in humans
Jean-Marie Galano et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2013)
Thromboxane-induced actin polymerization in hypoxic pulmonary artery is independent of Rho
Jena Fediuk et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2012)
Glutathione promotes prostaglandin H synthase (cyclooxygenase)-dependent formation of malondialdehyde and 15(S)-8-iso-prostaglandin F2α
Dimitrios Tsikas et al.
FEBS LETTERS (2012)
Urinary excretion of iPF2α-III predicts the risk of future thrombotic events. A 10-year follow-up
Matteo Nicola Dario Di Minno et al.
THROMBOSIS RESEARCH (2012)
EV-077 in vitro inhibits platelet aggregation in type-2 diabetics on aspirin
Kjell S. Sakariassen et al.
THROMBOSIS RESEARCH (2012)
Inherited Human gp91phox Deficiency Is Associated With Impaired Isoprostane Formation and Platelet Dysfunction
Pasquale Pignatelli et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Contractile effects of 15-E2t-isoprostane and 15-F2t-isoprostane on chicken embryo ductus arteriosus
Saskia van der Sterren et al.
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY A-MOLECULAR & INTEGRATIVE PHYSIOLOGY (2011)
F2-isoprostanes as an indicator and risk factor for coronary heart disease
Sean S. Davies et al.
FREE RADICAL BIOLOGY AND MEDICINE (2011)
Nonenzymatic free radical-catalyzed generation of 15-deoxy-Delta(12,14)-prostaglandin J(2)-like compounds (deoxy-J(2)-isoprostanes) in vivo
Klarissa D. Hardy et al.
JOURNAL OF LIPID RESEARCH (2011)
Platelet receptor signaling in thrombus formation
David Stegner et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2011)
Oxidative Stress Measured by Urine F2-Isoprostane Level is Associated With Prostate Cancer
Daniel A. Barocas et al.
JOURNAL OF UROLOGY (2011)
Increased Cerebrospinal Fluid F2-Isoprostanes are Associated with Aging and Latent Alzheimer's Disease as Identified by Biomarkers
Thomas J. Montine et al.
NEUROMOLECULAR MEDICINE (2011)
Emotion Recollected in Tranquility: Lessons Learned from the COX-2 Saga
Tilo Grosser et al.
ANNUAL REVIEW OF MEDICINE (2010)
Expression of thromboxane synthase, prostacyclin synthase and thromboxane receptor in atherosclerotic lesions: Correlation with plaque composition
Tillmann Cyrus et al.
ATHEROSCLEROSIS (2010)
Hypoxia-induced hyperreactivity of pulmonary arteries: role of cyclooxygenase-2, isoprostanes, and thromboxane receptors
Estelle Delannoy et al.
CARDIOVASCULAR RESEARCH (2010)
Redox-generated isoprostanes are associated with residual platelet activity in aspirin-treated patients with stable coronary heart disease
E. Schwedhelm et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
Thromboxane receptor α mediates tumor growth and angiogenesis via induction of vascular endothelial growth factor expression in human lung cancer cells
Jingyan Wei et al.
LUNG CANCER (2010)
Activated platelets and atherosclerosis
Pal Aukrust et al.
EXPERT REVIEW OF CARDIOVASCULAR THERAPY (2010)
Inhibition of Rho-dependent kinases ROCK I/II activates VEGF-driven retinal neovascularization and sprouting angiogenesis
Jens Kroll et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2009)
Ligand-Specific Conformation Determines Agonist Activation and Antagonist Blockade in Purified Human Thromboxane A2 Receptor
Ke-He Ruan et al.
BIOCHEMISTRY (2009)
Oxidative stress and human diseases: Origin, link, measurement, mechanisms, and biomarkers
Daniela Giustarini et al.
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES (2009)
Urinary 8-isoprostane levels can indicate the presence, severity and extent of angiographic coronary artery disease
Ibrahim Basarici et al.
ACTA CARDIOLOGICA (2008)
Characterization of isoprostane signaling:: Evidence for a unique coordination profile of 8-iso-PGF2α with the thromboxane A2 receptor, and activation of a separate cAMP-dependent inhibitory pathway in human platelets
Fadi T. Khasawneh et al.
BIOCHEMICAL PHARMACOLOGY (2008)
Differential regulation of RhoA-mediated signaling by the TPα and TPβ isoforms of the human thromboxane A2 receptor:: Independent modulation of TPα signaling by prostacyclin and nitric oxide
Katarina Wikstroem et al.
CELLULAR SIGNALLING (2008)
Isoprostanes Inhibit Vascular Endothelial Growth Factor-Induced Endothelial Cell Migration, Tube Formation, and Cardiac Vessel Sprouting In Vitro, As Well As Angiogenesis In Vivo via Activation of the Thromboxane A2 Receptor A Potential Link Between Oxidative Stress and Impaired Angiogenesis
Ralf A. Benndorf et al.
CIRCULATION RESEARCH (2008)
Suppression of atherogenesis by overexpression of glutathione peroxidase-4 in apolipoprotein E-deficient mice
ZhongMao Guo et al.
FREE RADICAL BIOLOGY AND MEDICINE (2008)
The interaction between coronary endothelial dysfunction, local oxidative stress, and endogenous nitric oxide in humans
Shahar Lavi et al.
HYPERTENSION (2008)
Formation of highly reactive cyclopentenone isoprostane compounds (A3/J3-isoprostanes) in vivo from eicosapentaenoic acid
Joshua D. Brooks et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
High levels of urinary F2-isoprostanes predict cardiovascular mortality in postmenopausal women
Mark Roest et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2008)
Isoprostanes constrict human radial artery by stimulation of thromboxane receptors, Ca2+ release, and RhoA activation
Irem Mueed et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2008)
Thromboxane A(2): Physiology/pathophysiology, cellular signal transduction and pharmacology
Norimichi Nakahata
PHARMACOLOGY & THERAPEUTICS (2008)
Markers of oxidative damage in chronic heart failure: role in disease progression
Slavica Radovanovic et al.
REDOX REPORT (2008)
Associations of isoprostanes-related oxidative stress with surrogate subclinical indices and angiographic measures of atherosclerosis
Ibrahim Basarici et al.
CORONARY ARTERY DISEASE (2007)
Low expression of cell-surface thromboxane A2 receptor β-isoform through the negative regulation of its membrane traffic by proteasomes
Masako Sasaki et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2007)
Thromboxane hypersensitivity in hypoxic pulmonary artery myocytes: altered TP receptor localization and kinetics
Martha Hinton et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2007)
Mass spectrometric analysis of F2-isoprostanes:: Markers and mediators in human disease
Edzard Schwedhelm et al.
CURRENT PHARMACEUTICAL ANALYSIS (2007)
Heterodimerization of the α and β isoforms of the human thromboxane receptor enhances isoprostane signaling
Stephen J. Wilson et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Insights into oxidative stress: The isoprostanes
Paolo Montuschi et al.
CURRENT MEDICINAL CHEMISTRY (2007)
Cardiovascular pharmacology and physiology of the isoprostanes
Jean-Luc Cracowski et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2006)
An antiangiogenic neurokinin-B/thromboxane A2 regulatory axis
Saumen Pal et al.
JOURNAL OF CELL BIOLOGY (2006)
Differential mapping of the amino acids mediating agonist and antagonist coordination with the human thromboxane A2 receptor protein
Fadi T. Khasawneh et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Physiological significance of thromboxane A2 receptor dimerization
M Sasaki et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2006)
Different pathways for activation of extracellular signal-regulated kinase through thromboxane A2 receptor isoforms
K Miyosawa et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2006)
Biomarkers of oxidative damage in human disease
I Dalle-Donne et al.
CLINICAL CHEMISTRY (2006)
Release of free F2-isoprostanes from esterified phospholipids is catalyzed by intracellular and plasma platelet-activating factor acetylhydrolases
DM Stafforini et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Associations of plasma 8-isoprostane levels with the presence and extent of coronary stenosis in patients with coronary artery disease
B Wang et al.
ATHEROSCLEROSIS (2006)
Hypoxia induces hypersensitivity and hyperreactivity to thromboxane receptor agonist in neonatal pulmonary arterial myocytes
M Hinton et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2006)
The isoprostanes - Unique products of arachidonate peroxidation: Their role as mediators of oxidant stress
JD Morrow
CURRENT PHARMACEUTICAL DESIGN (2006)
Oxidative mediated lipid peroxidation recapitulates proarrhythmic effects on cardiac sodium channels
K Fukuda et al.
CIRCULATION RESEARCH (2005)
Involvement of thromboxane receptor in the proatherogenic effect of isoprostane F2α-III Evidence from apolipoprotein E- and LDL receptor-deficient mice
M Tang et al.
CIRCULATION (2005)
Oligomerization of the α and isoforms of the thromboxane A2 receptor:: Relevance to receptor signaling and endocytosis
G Laroche et al.
CELLULAR SIGNALLING (2005)
15-F2t-isoprostane exacerbates myocardial ischemia-reperfusion injury of isolated rat hearts
ZY Xia et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2005)
Role of angiogenesis in cardiovascular disease - A critical appraisal
R Khurana et al.
CIRCULATION (2005)
Thromboxane A2-induced contraction of rat caudal arterial smooth muscle involves activation of Ca2+ entry and Ca2+ sensitization:: Rho-associated kinase-mediated phosphorylation of MYPT1 at Thr-855, but not Thr-697
DP Wilson et al.
BIOCHEMICAL JOURNAL (2005)
Cyclooxygenase 1-dependent production of F2-isoprostane and changes in redox status during warm renal ischemia-reperfusion
F Favreau et al.
FREE RADICAL BIOLOGY AND MEDICINE (2004)
Thromboxane A2 receptor agonists antagonize the proangiogenic effects of fibroblast growth factor-2 -: Role of receptor internalization, thrombospondin-1, and αvβ3
AW Ashton et al.
CIRCULATION RESEARCH (2004)
Structural and functional characterization of the first intracellular loop of human thromboxane A2 receptor
L Geng et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2004)
The mechanism of oxidative stress stabilization of the thromboxane receptor in COS-7 cells
FO Valentin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Urinary 8-iso-prostaglandin F2α as a risk marker in patients with coronary heart disease -: A matched case-control study
E Schwedhelm et al.
CIRCULATION (2004)
Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury
J Vinten-Johansen
CARDIOVASCULAR RESEARCH (2004)
Roles of thromboxane A2 and prostacyclin in the development of atherosclerosis in apoE-deficient mice
T Kobayashi et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Thromboxane A2 receptor signaling inhibits vascular endothelial growth factor-induced endothelial cell differentiation and migration
AW Ashton et al.
CIRCULATION RESEARCH (2004)
The cyclopentenone product of lipid peroxidation, 15-A(2t)-isoprostane, is efficiently metabolized by HepG2 cells via conjugation with glutathione
GL Milne et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2004)
Intravascular thrombosis after hypoxia-induced pulmonary hypertension - Regulation by cyclooxygenase-2
GP Pidgeon et al.
CIRCULATION (2004)
The α, but not the β, isoform of the human thromboxane A2 receptor is a target for nitric oxide-mediated desensitization -: Independent modulation of TPα signaling by nitric oxide and prostacyclin
HM Reid et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
8-Isoprostane increases expression of interleukin-8 in human macrophages through activation of mitogen-activated protein kinases
H Scholz et al.
CARDIOVASCULAR RESEARCH (2003)
Evidence for enhanced 8-isoprostane plasma levels, as index of oxidative stress in vivo, in patients with coronary artery disease
C Vassalle et al.
CORONARY ARTERY DISEASE (2003)
Cardiopulmonary bypass as a cause of free radical-induced oxidative stress and enhanced blood-borne isoprostanes in humans
AT Ulus et al.
FREE RADICAL BIOLOGY AND MEDICINE (2003)
The isoprostane 8-iso-PGE2 stimulates endothelial cells to bind monocytes via cyclic AMP- and p38 MAP kinase-dependent signaling pathways
J Huber et al.
ANTIOXIDANTS & REDOX SIGNALING (2003)
Identification of residues important for ligand binding of thromboxane A2 receptor in the second extracellular loop using the NMR experiment-guided mutagenesis approach
SP So et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Abnormal angiogenesis in diabetes mellitus
A Martin et al.
MEDICINAL RESEARCH REVIEWS (2003)
Antioxidants significantly affect the formation of different classes of isoprostanes and neuroprostanes in rat cerebral synaptosomes
TJ Montine et al.
BIOCHEMICAL PHARMACOLOGY (2003)
G(13) is an essential mediator of platelet activation in hemostasis and thrombosis
A Moers et al.
NATURE MEDICINE (2003)
Dose-dependent protection of cardiac function by propofol during ischemia and early reperfusion in rats: effects on 15-F-2t-isoprostane formation
ZY Xia et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2003)
Role of angiogenesis in tumor growth and metastasis
J Folkman
SEMINARS IN ONCOLOGY (2002)
Increased oxidative stress and platelet activation in patients with hypertension and renovascular disease
P Minuz et al.
CIRCULATION (2002)
β2 integrin-dependent neutrophil adhesion induced by minimally modified low-density lipoproteins is mainly mediated by F2-isoprostanes
L Fontana et al.
CIRCULATION (2002)
Involvement of TP and EP3 receptors in vasoconstrictor responses to isoprostanes in pulmonary vasculature
LJ Janssen et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Mapping of a ligand-binding site for the human thromboxane A2 receptor protein
JW Turek et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Thromboxane receptor density is increased in human cardiovascular disease with evidence for inhibition at therapeutic concentrations by the AT1 receptor antagonist losartan
SD Katugampola et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
Identification and functional characterization of thromboxane A2 receptors in Schwann cells
N Muja et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Induction of gp91-phox, a component of the phagocyte NADPH oxidase, in microglial cells during central nervous system inflammation
SP Green et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2001)
Vascular biology of the isoprostanes
JL Cracowski et al.
JOURNAL OF VASCULAR RESEARCH (2001)
8-Iso-PGF(2 alpha) induces beta(2)-integrin-mediated rapid adhesion of human polymorphonuclear neutrophils - A link between oxidative stress and ischemia/reperfusion injury
L Fontana et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2001)
Vasoconstrictor actions of isoprostanes via tyrosine kinase and Rho kinase in human and canine pulmonary vascular smooth muscles
LJ Janssen et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
Abnormalities in apo B-containing lipoproteins in diabetes and atherosclerosis
GH Tomkin et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2001)
Characterization of prostanoid receptors mediating actions of the isoprostanes, 8-iso-PGE2 and 8-iso-PGF2α, in some isolated smooth muscle preparations
W Sametz et al.
BRITISH JOURNAL OF PHARMACOLOGY (2000)
Tandem mass spectrometric quantification of 8-iso-prostaglandin F2α and its metabolite 2,3-dinor-5,6-dihydro-8-iso-prostaglandin F2α in human urine
E Schwedhelm et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2000)
The thromboxane receptor antagonist S18886 but not aspirin inhibits atherogenesis in apo E-deficient mice - Evidence that eicosanoids other than thromboxane contribute to atherosclerosis
AJ Cayatte et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2000)
Cardiovascular responses to the isoprostanes iPF2α-III and iPE2-III are mediated via the thromboxane A2 receptor in vivo
LP Audoly et al.
CIRCULATION (2000)
Effects of some isoprostanes on the human umbilical artery in vitro
L Oliveira et al.
BRITISH JOURNAL OF PHARMACOLOGY (2000)
Augmented vasoconstriction and thromboxane formation by 15-F2t-isoprostane (8-iso-prostaglandin F2α) in immature pig periventricular brain microvessels
X Hou et al.
STROKE (2000)
Thromboxane A2 regulation of endothelial cell migration, angiogenesis, and tumor metastasis
DT Nie et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
分享论文
